As of 2025-07-12, the Fair Value of NextCure Inc (NXTC) is -8.91 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.40 USD, the upside of NextCure Inc is -2,356.37%.
With the market price of 0.40 USD and our fair value calculation, NextCure Inc (NXTC) is not a good investment. Investing in NXTC stocks now will result in a potential loss of 2,356.37%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -36.60 | -69.39 | -74.73 | -63.00 | -56.00 | -59.94 |
| YoY growth | -8.48% | -89.59% | -7.70% | 15.70% | 11.11% | -15.79% |
| Market Cap (mil) | 11.08 |
| P/E | |
| Forward P/E |
| EPS | -1.78 |
| Avg earnings growth rate | -15.79% |
| TTM earnings | -50.00 |